Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB26FD1BE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,673
Award facts
- Contract value 100% obligated
- $1,673.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,673.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Tymlos 80 mcg dose pen injectables (1.56 mL). The delivery order, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, was issued without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This award represents one of numerous delivery orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division during October 2025.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense military healthcare facilities worldwide. The underlying IDC, designated as contract SPE2DR with a ceiling value of $499,999,999 and completion date of December 31, 2036, provides a structured 30-month base period with three 30-month option periods. As a regional prime vendor contractor, DMS Pharmaceutical Group has demonstrated substantial capability across a comprehensive pharmaceutical portfolio including specialty medications, biologics, vaccines, and medical consumables to support recurring DoD medical supply requirements globally.
Quick answers
Who was awarded contract SPE2DB26FD1BE?
SPE2DB26FD1BE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FD1BE worth?
The government has obligated $1,673 on SPE2DB26FD1BE.
Is contract SPE2DB26FD1BE an order under another contract?
Yes. SPE2DB26FD1BE is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB26FD1BE competed?
The extent of competition for SPE2DB26FD1BE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award